Resolvyx Pharmaceuticals

... the end in inflammation

Management Team

Resolvyx has brought together a team of dedicated, innovative scientists who bring a broad range of skills and expertise to move forward this ground breaking technology.

Greg Weinhoff
Greg Weinhoff, MD
Executive Chairman
James Nichols
James Nichols, PhD
President and CEO
Per Gjorstrup
Per Gjorstrup, MD PhD
Co-founder and
Chief Medical Officer

The Resolvin "many-to-one" approach will, for the first time, address the immune system redundancy as a major obstacle to identifying highly efficacious therapies for chronic inflammatory diseases.